Published in Obesity and Diabetes Week, July 17th, 2006
"Resistin, a cysteine-rich 12.5 kDa polypeptide, is a recently discovered adipocytokine with a controversial history regarding its role in the pathogenesis of obesity-mediated insulin resistance and type 2 diabetes mellitus. Whilst current studies appear to reaffirm the role of resistin on glucose homeostasis in rodent systems, we are still unraveling the functionality of resistin in human biology in respect to glucose metabolism and insulin signaling,"...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.